Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ishares Nasdaq Biotechnology (IBB)

282.87
Delayed Data
As of Aug 25
 -3.36 / -1.17%
Today’s Change
240.03
Today|||52-Week Range
366.56
-16.39%
Year-to-Date
Mylan EpiPen Scrutiny Puts More Biotechs at Risk
Aug 25 / TheStreet.com - Paid Partner Content
Rough Month: A Closer Look At Ligand's Fall From All-Time Highs
Aug 24 / Benzinga - Paid Partner Content
Mylan EpiPen Controversy Puts More Biotechs in Danger
Aug 25 / TheStreet.com - Paid Partner Content
Hillary Clinton Blasts Drug Prices, Biotech Stocks Plunge. Yes, It Could Be Happening...
Aug 24 / TheStreet.com - Paid Partner Content
Mylan Dispute Puts More Biotechs in Danger
Aug 25 / TheStreet.com - Paid Partner Content
Why You Should (and Shouldn't) Buy Gilead Sciences, Inc.
Aug 24 / MotleyFool.com - Paid Partner Content
Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan (MYL) Stock?
Aug 24 / Zacks.com - Paid Partner Content
3 ETFs to Play Biotech's Bounce Back From Disaster
Aug 19 / TheStreet.com - Paid Partner Content